ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
mool
|
13K |
5.0M |
6 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
mool
|
13K |
5.0M |
27 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
mool
|
13K |
5.0M |
3 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
mool
|
3.1K |
1.4M |
9 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
mool
|
9.8K |
2.9M |
2 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
9.8K
|
2.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
mool
|
13K |
5.0M |
10 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
10
|
|
ASX - By Stock
|
OVT |
Re:
Ann: ICU Announces Technology Platform Improvements
|
|
mool
|
71 |
22K |
0 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
71
|
22K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
mool
|
53 |
25K |
13 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
53
|
25K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
mool
|
5.4K |
2.6M |
8 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
5.4K
|
2.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
mool
|
2.3K |
904K |
12 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.3K
|
904K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
8-2 VICTORY! Now what do we open at?
|
|
mool
|
67 |
30K |
6 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
67
|
30K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
8-2 VICTORY! Now what do we open at?
|
|
mool
|
67 |
30K |
14 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
67
|
30K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
mool
|
2.0K |
689K |
10 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
689K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
mool
|
2.3K |
904K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
904K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
mool
|
2.3K |
904K |
8 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
904K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
5 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
3 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
36 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
23K
|
13M
|
36
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
10 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
ARDS Trial - From UPenn Principal Investigator
|
|
mool
|
41 |
26K |
5 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
41
|
26K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
1 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
mool
|
854 |
430K |
3 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
854
|
430K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Countdown to Interim Analysis
|
|
mool
|
195 |
71K |
15 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
195
|
71K
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
3 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
mool
|
3.5K |
2.3M |
4 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
3.5K
|
2.3M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
50 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23K
|
13M
|
50
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
9 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
mool
|
23K |
13M |
3 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
mool
|
17K |
6.7M |
4 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
mool
|
1.0K |
490K |
6 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
1.0K
|
490K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
mool
|
933 |
435K |
1 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
933
|
435K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
mool
|
933 |
435K |
5 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
933
|
435K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
$MESO Started Phase 2/3 Covid ARDS trial 3 days ago with 6 locations now expanded to 14!
|
|
mool
|
87 |
48K |
8 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
87
|
48K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Googala's 2020 Share Price Competitions
|
|
mool
|
303 |
102K |
1 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
303
|
102K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Ivory Coast
|
|
mool
|
112 |
48K |
0 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
112
|
48K
|
0
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Q1 2020 Business Update and Presentation
|
|
mool
|
24 |
9.7K |
1 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
24
|
9.7K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Q1 2020 Business Update and Presentation
|
|
mool
|
24 |
9.7K |
0 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
24
|
9.7K
|
0
|
|
Charts
|
FLC |
Re:
Chart
|
|
mool
|
8.0K |
3.5M |
1 |
23/04/20 |
23/04/20 |
Charts
|
8.0K
|
3.5M
|
1
|
|
Charts
|
FLC |
Re:
Chart
|
|
mool
|
8.0K |
3.5M |
0 |
23/04/20 |
23/04/20 |
Charts
|
8.0K
|
3.5M
|
0
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Update Regarding China Operations and the Coronavirus
|
|
mool
|
27 |
17K |
19 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
27
|
17K
|
19
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Appendix 4C - quarterly
|
|
mool
|
114 |
70K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
114
|
70K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
mool
|
3.5K |
2.3M |
0 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
3.5K
|
2.3M
|
0
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Achieves Financial Close for Ivory Coast Project
|
|
mool
|
108 |
56K |
1 |
08/01/20 |
08/01/20 |
ASX - By Stock
|
108
|
56K
|
1
|
|
Charts
|
FLC |
Re:
Chart
|
|
mool
|
8.0K |
3.5M |
0 |
09/12/19 |
09/12/19 |
Charts
|
8.0K
|
3.5M
|
0
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Successfully Raises $36.0 Million to Underpin Growth
|
|
mool
|
95 |
42K |
0 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
95
|
42K
|
0
|
|
ASX - By Stock
|
FLC |
Re:
Announcement by Email
|
|
mool
|
3 |
2.2K |
2 |
03/05/19 |
03/05/19 |
ASX - By Stock
|
3
|
2.2K
|
2
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
mool
|
16 |
7.2K |
1 |
18/04/19 |
18/04/19 |
ASX - By Stock
|
16
|
7.2K
|
1
|
|
Charts
|
FLC |
Re:
Chart
|
|
mool
|
8.0K |
3.5M |
7 |
18/04/19 |
18/04/19 |
Charts
|
8.0K
|
3.5M
|
7
|
|
Charts
|
FLC |
Re:
Chart
|
|
mool
|
8.0K |
3.5M |
2 |
22/03/19 |
22/03/19 |
Charts
|
8.0K
|
3.5M
|
2
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence signs second large contract in Egypt
|
|
mool
|
66 |
24K |
0 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
66
|
24K
|
0
|
|